Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “multiple sclerosis”
Sponsor: University Hospital, Strasbourg, France
Multiple Sclerosis (MS)
France
- Study of Circadian Focused Light Therapy in Progressive Multiple SclerosisEnrolling By Invitation
Sponsor: University of Texas Southwestern Medical Center
Progressive Multiple Sclerosis
United States
Sponsor: University Hospital, Toulouse
Multiple Sclerosis
France
Sponsor: Tokat Gaziosmanpasa University
Multiple Sclerosis · Fatigue · Sleep Quality · Psychological Well-being
Turkey (Türkiye)
Sponsor: Nurgül KAPLAN
Multiple Sclerosis · Urinary Incontinence
Turkey (Türkiye)
- Early Versus Late Ofatumumab (Kesimpta®) Use in Austrian RMS-Patients Over 2 YearsActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Relapsing Multiple Sclerosis
- Normal Chinese Lifespan Brain Charts Initiative (NCLBCI)Enrolling By Invitation
Sponsor: Beijing Tiantan Hospital
Healthy · Multiple Sclerosis · Neuromyelitis Optica Spectrum Disorders · Neurodegenerative Diseases
China
- Implementation of an Advanced Telerehabilitation Solution for People With Multiple SclerosisNot Yet Recruiting
Sponsor: Danish Multiple Sclerosis Hospitals
Multiple Sclerosis
Denmark, Ireland, Israel, Italy
Sponsor: Massachusetts General Hospital
Multiple Sclerosis
United States
Sponsor: University of Pittsburgh
Multiple Sclerosis
United States
Sponsor: Sanko University
MULTİPLE SCLEROSİS · BALANCE · VALİDİTY · RELİABİLİTY
Turkey (Türkiye)
Sponsor: Novartis Pharmaceuticals
Relapsing Forms of Multiple Sclerosis
Spain
Sponsor: Sheffield Hallam University
Multiple Sclerosis
United Kingdom
- Clinically Isolated Syndrome and Relapsing-Remitting Multiple SclerosisActive Not Recruiting
Sponsor: Terry L. Wahls
Clinically Isolated Syndrome · Relapsing Remitting Multiple Sclerosis
United States
- Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast AgentCompleted
Sponsor: Reveal Pharmaceuticals Inc.
Central Nervous System (CNS) Lesions · Brain Metastases · Brain Neoplasms · Brain Neoplasms, Benign
United States
Sponsor: University Hospital, Basel, Switzerland
Multiple Sclerosis · Multiple Sclerosis, Relapsing-Remitting · Multiple Sclerosis, Primary Progressive · Multiple Sclerosis, Secondary Progressive
Switzerland
Sponsor: Oxford University Hospitals NHS Trust
Centreal Neurological Condition · Acquired Brain Injury (Including Stroke) · Multiple Sclerosis · Spinal Cord Injury
United Kingdom
- Multiple Sclerosis Versus Neuromyelitis Optica Spectrum DisorderNot Yet Recruiting
Sponsor: Assiut University
MS (Multiple Sclerosis) · NMO Spectrum Disorder (NMOSD)
- Emotions in Multiple SclerosisCompleted
Sponsor: Lille Catholic University
Multiple Sclerosis
France
- ALS Phase II Study of NX210cActive Not Recruiting
Sponsor: Axoltis Pharma
Amyotrophic Lateral Sclerosis
France
- Survey Among Healthcare Professionals and MS Patients to Assess Their Understanding of RMP MaterialsCompleted
Sponsor: Novartis Pharmaceuticals
Multiple Sclerosis
Switzerland
- Intermediate Expanded Access Protocol CNMAu8.EAP03Temporarily Not Available
Sponsor: Clene Nanomedicine
Multiple Sclerosis
United States
- A Study of Ocrelizumab in Children and Adolescents With Relapsing-Remitting Multiple SclerosisActive Not Recruiting
Sponsor: Hoffmann-La Roche
Multiple Sclerosis
United States, Italy, Poland
- Transcutaneous Tibial Neuro-stimulation to Improve Voiding Dysfunction in Multiple Sclerosis.Recruiting
Sponsor: University Hospital, Lille
Multiple Sclerosis · Lower Urinary Tract Symptoms
France
Sponsor: Centre Hospitalier Régional d'Orléans
Kidney Transplant · Myeloma · Cancer · Hematologic Malignancy
France